(MGRM) Monogram Orthopaedics - Ratings and Ratios

Monogram Technologies Inc., formerly known as Monogram Orthopaedics Inc., is a US-based company that specializes in the development of surgical robots designed to facilitate the placement of customized orthopedic implants. The companys product portfolio encompasses a range of robotic surgical equipment, software, orthopedic implants, and related instrumentation for reconstructive joint replacement procedures. With its headquarters in Austin, Texas, Monogram Technologies was founded in 2015 and has since rebranded in May 2024.

The companys focus on innovative surgical robotics and orthopedic solutions positions it within the Health Care Equipment sub-industry, as classified by the GICS. As a publicly traded company listed on NASDAQ under the ticker symbol MGRM, Monogram Technologies Inc. is subject to market scrutiny and investor interest. The companys website (https://www.monogramtechnologies.com) provides further insights into its mission, products, and technological advancements.

Analyzing the available and , we can observe that Monogram Technologies Inc. has a market capitalization of $101.99M USD, indicating a relatively small-cap stock. The absence of a P/E ratio and forward P/E ratio suggests that the company is currently not profitable. The Return on Equity (RoE) stands at -128.82, further indicating significant losses. From a technical standpoint, the stocks last price is $2.59, with its 200-day Simple Moving Average (SMA) at $2.59, suggesting a stable short-term trend. The Average True Range (ATR) of 0.22 represents an 8.44% volatility, which is relatively high.

Forecasting the stocks performance based on the provided data, a potential trend reversal or stabilization could be anticipated if the company addresses its profitability concerns. The current SMA20 and SMA50 values are at $2.75, slightly above the last price, indicating a potential resistance level. If Monogram Technologies Inc. can demonstrate progress in its product development and commercialization, thereby potentially improving its financials, the stock might experience a positive momentum. Conversely, failure to address the current losses and improve profitability could lead to continued volatility and downward pressure on the stock price. Therefore, a key factor to monitor would be the companys ability to transition towards profitability and the markets reaction to such developments.